{
    "id": 22337,
    "fullName": "STAG2 N357fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "STAG2 N357fs results in a change in the amino acid sequence of the Stag2 protein beginning at aa 357 of 1231, likely resulting in premature truncation of the functional protein (UniProt.org). N357fs results in a loss of Stag2 protein expression and defective sister chromatid cohesion and is associated with chromosomal instability in cell culture (PMID: 21852505).",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 10735,
        "geneSymbol": "STAG2",
        "terms": [
            "STAG2",
            "bA517O1.1",
            "MKMS",
            "NEDXCF",
            "SA-2",
            "SA2",
            "SCC3B"
        ]
    },
    "variant": "N357fs",
    "createDate": "05/10/2016",
    "updateDate": "08/27/2018",
    "referenceTranscriptCoordinates": {
        "id": 153555,
        "transcript": "NM_001282418",
        "gDna": "chrX:g.(124051171_124051172)",
        "cDna": "c.(1069_1068)",
        "protein": "p.N357fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6214,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a glioblastoma cell line harboring a STAG2 mutation (reported as STAG2 N357fs, PMID: 21852505) demonstrated increased sensitivity to treatment with Veliparib (ABT-888) in culture compared to isogenic cells with wild-type STAG2 (PMID: 24356817).",
            "molecularProfile": {
                "id": 22904,
                "profileName": "STAG2 N357fs"
            },
            "therapy": {
                "id": 954,
                "therapyName": "Veliparib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 5471,
                    "pubMedId": 24356817,
                    "title": "Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24356817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6213,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a glioblastoma cell line harboring a STAG2 mutation (reported as STAG2 N357fs, PMID: 21852505) demonstrated increased sensitivity to treatment with Lynparza (olaparib) in culture, resulting in decreased proliferation and colony formation, and increased DNA damage compared to isogenic cells with wild-type STAG2 (PMID: 24356817).",
            "molecularProfile": {
                "id": 22904,
                "profileName": "STAG2 N357fs"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 5471,
                    "pubMedId": 24356817,
                    "title": "Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24356817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6215,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a glioblastoma cell line harboring a STAG2 mutation (reported as STAG2 N357fs, PMID: 21852505), demonstrated increased sensitivity to treatment with Rubraca (rucaparib) in culture compared to isogenic cells with wild-type STAG2 (PMID: 24356817).",
            "molecularProfile": {
                "id": 22904,
                "profileName": "STAG2 N357fs"
            },
            "therapy": {
                "id": 906,
                "therapyName": "Rucaparib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 5471,
                    "pubMedId": 24356817,
                    "title": "Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24356817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6219,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, glioblastoma cells harboring a STAG2 mutation (reported as STAG2 N357fs, PMID: 21852505) demonstrated increased sensitivity to the combination of Lynparza (olaparib) and camptothecin compared to isogenic cells with wild-type STAG2 in culture (PMID: 24356817).",
            "molecularProfile": {
                "id": 22904,
                "profileName": "STAG2 N357fs"
            },
            "therapy": {
                "id": 4095,
                "therapyName": "Camptothecin + Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 5471,
                    "pubMedId": 24356817,
                    "title": "Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24356817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6218,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, glioblastoma cells harboring a STAG2 mutation (reported as STAG2 N357fs, PMID: 21852505) demonstrated increased sensitivity to the combination of Lynparza (olaparib) and Temodar (temozolomide) compared to isogenic cells with wild-type STAG2 in culture (PMID: 24356817).",
            "molecularProfile": {
                "id": 22904,
                "profileName": "STAG2 N357fs"
            },
            "therapy": {
                "id": 1438,
                "therapyName": "Olaparib + Temozolomide",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5470,
                    "pubMedId": 21852505,
                    "title": "Mutational inactivation of STAG2 causes aneuploidy in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21852505"
                },
                {
                    "id": 5471,
                    "pubMedId": 24356817,
                    "title": "Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24356817"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 22904,
            "profileName": "STAG2 N357fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 153563,
            "transcript": "NM_006603",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153553,
            "transcript": "XM_005262357",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153564,
            "transcript": "XM_005262359",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153557,
            "transcript": "XM_005262358",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153566,
            "transcript": "XM_017029233",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153560,
            "transcript": "XM_017029234",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153558,
            "transcript": "XM_011531253",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153565,
            "transcript": "XM_005262360",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153554,
            "transcript": "XM_005262361",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153562,
            "transcript": "NM_001042751",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153559,
            "transcript": "XM_017029232",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153561,
            "transcript": "NM_001042750",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153555,
            "transcript": "NM_001282418",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153556,
            "transcript": "XM_006724727",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 153552,
            "transcript": "NM_001042749",
            "gDna": "chrX:g.(124051171_124051172)",
            "cDna": "c.(1069_1068)",
            "protein": "p.N357fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}